SIGNYDYN Trademark

Trademark Overview

On Thursday, August 26, 2010, a trademark application was filed for SIGNYDYN with the United States Patent and Trademark Office. The USPTO has given the SIGNYDYN trademark a serial number of 85116776. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 5, 2014. This trademark is owned by Novartis AG. The SIGNYDYN trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antibiotic preparations; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology and for use in the gastroenterological area
signydyn

General Information

Serial Number85116776
Word MarkSIGNYDYN
Filing DateThursday, August 26, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 5, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 1, 2011

Trademark Statements

Goods and ServicesAnti-infectives; Antibiotic preparations; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology and for use in the gastroenterological area

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 2, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, May 5, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 5, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2013EXTENSION 5 GRANTED
Friday, September 13, 2013EXTENSION 5 FILED
Friday, September 13, 2013TEAS EXTENSION RECEIVED
Thursday, March 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2013EXTENSION 4 GRANTED
Tuesday, March 12, 2013EXTENSION 4 FILED
Tuesday, March 12, 2013TEAS EXTENSION RECEIVED
Friday, September 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 27, 2012EXTENSION 3 GRANTED
Tuesday, September 25, 2012EXTENSION 3 FILED
Tuesday, September 25, 2012TEAS EXTENSION RECEIVED
Thursday, April 5, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 4, 2012EXTENSION 2 GRANTED
Wednesday, March 14, 2012EXTENSION 2 FILED
Wednesday, April 4, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 14, 2012TEAS EXTENSION RECEIVED
Saturday, September 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 15, 2011EXTENSION 1 GRANTED
Thursday, September 15, 2011EXTENSION 1 FILED
Thursday, September 15, 2011TEAS EXTENSION RECEIVED
Tuesday, March 29, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 1, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 1, 2011PUBLISHED FOR OPPOSITION
Monday, December 27, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 27, 2010ASSIGNED TO LIE
Thursday, December 2, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 1, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 1, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 22, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 22, 2010NON-FINAL ACTION E-MAILED
Monday, November 22, 2010NON-FINAL ACTION WRITTEN
Monday, November 22, 2010REMOVED FROM TEAS PLUS
Monday, November 22, 2010ASSIGNED TO EXAMINER
Tuesday, August 31, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 30, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

signydyn system disorders diseases preparations treatment pharmaceutical prevention genitourinary inflammatory respiratory